BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29672331)

  • 1. Tigecycline-Associated Acute Pancreatitis.
    Akhter S; Krishnan P; Kaul P
    Am J Ther; 2018; 25(6):e749-e750. PubMed ID: 29672331
    [No Abstract]   [Full Text] [Related]  

  • 2. Tigecycline-induced acute pancreatitis: case report and literature review.
    Hung WY; Kogelman L; Volpe G; Iafrati M; Davidson L
    Int J Antimicrob Agents; 2009 Nov; 34(5):486-9. PubMed ID: 19540093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute pancreatitis caused by tigecycline: A case report and literature review.
    Wang PF; Zou H; Zhu JH; Shi FE
    Medicine (Baltimore); 2021 Dec; 100(51):e28245. PubMed ID: 34941095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline-induced acute pancreatitis in a renal transplant patient: a case report and literature review.
    Lin J; Wang R; Chen J
    BMC Infect Dis; 2018 May; 18(1):201. PubMed ID: 29720098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of age on the clinical efficacy of tigecycline in severely ill patients.
    Bassetti M; Guirao X; Montravers P; Rossolini GM; Sánchez García M; Sganga G; Eckmann C
    J Glob Antimicrob Resist; 2019 Sep; 18():199-206. PubMed ID: 30953830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of clinical characteristics of tigecycline-induced acute pancreatitis.
    Fang W; Yi D; Sun L; Wang C
    J Clin Pharm Ther; 2020 Dec; 45(6):1320-1324. PubMed ID: 32649800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pancreatitis related to tigecycline: case report and review of the literature.
    Gilson M; Moachon L; Jeanne L; Dumaine V; Eyrolle L; Morand P; Ben m'Rad M; Salmon D
    Scand J Infect Dis; 2008; 40(8):681-3. PubMed ID: 18979610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute pancreatitis caused by tigecycline and furosemide combination treatment and hypofibrinogenemia caused by tigecycline: A case report.
    Li ZK; Zheng P
    Int J Clin Pharmacol Ther; 2023 Oct; 61(10):466-470. PubMed ID: 37548456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute pancreatitis in ICU secondary to treatment with tigecycline.
    Bernas Albeniz A; Aveiga Valencia DA; Etxeberria Zabala L; Zaldibar-Gerrikagoitia Bilbao J; Aguilera Celorrio L
    Rev Esp Anestesiol Reanim; 2017 Jan; 64(1):46-49. PubMed ID: 27609674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tigecycline-induced acute pancreatitis: about two cases and review of the literature.
    Marot JC; Jonckheere S; Munyentwali H; Belkhir L; Vandercam B; Yombi JC
    Acta Clin Belg; 2012; 67(3):229-32. PubMed ID: 22897076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline-associated acute pancreatitis in a child with pulmonary cystic fibrosis: A case report and literature review.
    Chang C; Qiao W; Wang H; Zhang X
    Int J Clin Pharmacol Ther; 2022 Jan; 60(1):41-45. PubMed ID: 34605395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Case of Skin and Soft Tissue Infection Caused by Mycoplasma hominis in a Pediatric Immunocompromised Patient.
    Cho H; Park KG; Han SB; Chung NG; Park YJ
    Ann Lab Med; 2017 Jul; 37(4):346-348. PubMed ID: 28445018
    [No Abstract]   [Full Text] [Related]  

  • 13. True incidence of tigecycline-induced pancreatitis: how many cases are we missing?
    Davido B; Shourick J; Makhloufi S; Dinh A; Salomon J
    J Antimicrob Chemother; 2016 Oct; 71(10):2994-5. PubMed ID: 27365188
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.
    Sacchidanand S; Penn RL; Embil JM; Campos ME; Curcio D; Ellis-Grosse E; Loh E; Rose G
    Int J Infect Dis; 2005 Sep; 9(5):251-61. PubMed ID: 16099700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary experience with tigecycline treatment for severe infection in children.
    Ye S; Zhang C; Lin S
    Eur J Pediatr; 2018 Oct; 177(10):1489-1496. PubMed ID: 30008076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective.
    Teras J; Gardovskis J; Vaasna T; Kupcs U; Pupelis G; Dukart G; Dartois N; Jouve S; Cooper A;
    J Chemother; 2008 Oct; 20 Suppl 1():20-7. PubMed ID: 19036671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline-related pancreatitis: a review of spontaneous adverse event reports.
    Okon E; Engell C; van Manen R; Brown J
    Pharmacotherapy; 2013 Jan; 33(1):63-8. PubMed ID: 23307547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.
    Ellis-Grosse EJ; Babinchak T; Dartois N; Rose G; Loh E; ;
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S341-53. PubMed ID: 16080072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tigecycline: an update.
    Stein GE; Babinchak T
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):331-6. PubMed ID: 23357291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan.
    Chuang YC; Chang CM; Aradhya S; Nagari B; Pai V; Dartois N; Jouve S; Cooper A
    J Microbiol Immunol Infect; 2011 Apr; 44(2):116-24. PubMed ID: 21439514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.